Americana Partners, LLC Abb Vie Inc. Transaction History

Americana Partners, LLC

$1.36 Billion
Q3 2024

A detailed history of Americana Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Americana Partners, LLC holds 73,572 shares of ABBV stock, worth $12.9 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares

73,572

Previous 71,214 3.31%

Holding current value

$12.9 Million

Previous $12.2 Million 18.95%

% of portfolio

1.07%

Previous 1.05%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$163.84 - $199.33 $386,334 - $470,020	2,358 Added 3.31%	73,572 $14.5 Million
Q2 2024 Jul 30, 2024	BUY	$154.79 - $180.76 $158,040 - $184,555	1,021 Added 1.45%	71,214 $12.2 Million
Q1 2024 May 07, 2024	SELL	$159.82 - $182.1 $260,826 - $297,187	-1,632 Reduced 2.27%	70,193 $12.8 Million
Q4 2023 Jan 25, 2024	BUY	$137.6 - $154.97 $2.46 Million - $2.77 Million	17,900 Added 33.19%	71,825 $11.1 Million
Q3 2023 Nov 07, 2023	BUY	$133.59 - $154.65 $240,462 - $278,370	1,800 Added 3.45%	53,925 $8.04 Million
Q2 2023 Jul 31, 2023	BUY	$132.51 - $164.9 $306,893 - $381,908	2,316 Added 4.65%	52,125 $7.02 Million
Q1 2023 May 08, 2023	BUY	$144.61 - $166.54 $1,879 - $2,165	13 Added 0.03%	49,809 $7.94 Million
Q4 2022 Jan 30, 2023	SELL	$138.31 - $165.87 $2.06 Million - $2.47 Million	-14,867 Reduced 22.99%	49,796 $8.05 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $2.52 Million - $2.89 Million	18,747 Added 40.83%	64,663 $8.67 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $4.17 Million - $5.3 Million	30,290 Added 193.84%	45,916 $6.91 Million
Q1 2022 May 06, 2022	SELL	$131.98 - $163.75 $2.53 Million - $3.14 Million	-19,150 Reduced 55.07%	15,626 $2.47 Million
Q4 2021 Jan 28, 2022	BUY	$107.43 - $135.93 $2.08 Million - $2.63 Million	19,334 Added 125.2%	34,776 $4.71 Million
Q3 2021 Nov 08, 2021	BUY	$106.4 - $120.78 $1.64 Million - $1.87 Million	15,442 New	15,442 $1.67 Million
Q2 2020 Aug 12, 2020	SELL	$73.37 - $98.18 $202,647 - $271,173	-2,762 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $154,800 - $234,696	2,400 Added 662.98%	2,762 $210,000
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $26,111 - $32,670	362 New	362 $32,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Americana Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Americana Partners, LLC with notifications on news.

Account

Americana Partners, LLC Abb Vie Inc. Transaction History